Retraction: Enhancer RNA SLIT2 inhibits bone metastasis of breast cancer through regulating P38 MAPK/c-Fos signaling pathway - Summary - MDSpire

Retraction: Enhancer RNA SLIT2 inhibits bone metastasis of breast cancer through regulating P38 MAPK/c-Fos signaling pathway

  • May 7, 2026

  • 0 min

Share

Objective:

To inform about the retraction process of the original research article regarding the role of enhancer RNA SLIT2 in breast cancer bone metastasis.

Key Findings:
  • Image duplication concerns were identified in Figures 8 and 9, raising significant questions about the reliability of the research.
  • The authors did not provide a satisfactory explanation during the investigation, further undermining trust in the findings.
  • The data and conclusions of the article were deemed unreliable, impacting the credibility of the research.
Interpretation:

The retraction indicates a failure to maintain research integrity, which has serious implications for the scientific record and community.

Limitations:
  • The investigation did not yield satisfactory explanations from the authors, highlighting a gap in accountability.
  • Concerns about image integrity undermine the reliability of the research, affecting future studies in the field.
Conclusion:

The article has been officially retracted by the journal due to integrity issues, with approval from editorial leadership, emphasizing the importance of maintaining research integrity.

Original Source(s)

Related Content